Atlas Trials

Gannex Pharma Co., Ltd.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Gannex Pharma Co., Ltd.

RecordFirmDate
Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH (NCT05118360)Gannex Pharma Co., Ltd.2023-12-01
Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH (NCT05462353)Gannex Pharma Co., Ltd.2022-09-30
Drug Interaction Study of ASC42 With Atorvastatin (NCT05464628)Gannex Pharma Co., Ltd.2022-08-08
Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis (NCT05190523)Gannex Pharma Co., Ltd.2022-04-06
Safety, Tolerability, and Pharmacokinetics of ASC43F, a Fixed Dose Combination Tablet in Healthy Subjects (NCT05118516)Gannex Pharma Co., Ltd.2021-11-01
DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD. (NCT04845646)Gannex Pharma Co., Ltd.2021-03-16
Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers (NCT04692025)Gannex Pharma Co., Ltd.2020-12-27
Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects (NCT04686994)Gannex Pharma Co., Ltd.2020-12-22
Study to Evaluate Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ASC42 in Healthy Subjects (NCT04679129)Gannex Pharma Co., Ltd.2020-11-30

Track Gannex Pharma Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.